Anavex Life Sciences Corp (AVXL)

[Investor2014]

For one reason because both the subject RSBQ and to a lesser degree CGI-I scores are notoriously unreliable.

It is what it is and could likely have been dealt with by a larger and longer trial.

As I have mentioned positive biomarker correlations to the dose arm could be helpful also from the OLE and compassionate patients having been on drug for longer.

We will hopefully get some information on that at some point.